Safety and efficacy of combined transrectal ultrasound-guided prostate needle biopsy and transurethral resection of the prostate

Korean Journal of Urology

Volumn 51, Issue 2, 2010, Pages 101-105

  Cho, Jeong Man ^a   Lee, Seung Wook ^a   Kang, Jung Yoon ^a   Yoo, Tag Keun ^a  

^a Eulji General Hospital   (South Korea)

Author keywords

Biopsy; Prostatic hyperplasia; Prostatic neoplasms; Transurethral resection of prostate

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; DIAGNOSTIC ACCURACY; FEVER; HUMAN; MALE; NEEDLE BIOPSY; PROSTATE CANCER; PROSTATE HYPERTROPHY; TRANSRECTAL ULTRASONOGRAPHY; TRANSRECTAL ULTRASOUND GUIDED PROSTATE NEEDLE BIOPSY; TRANSURETHRAL RESECTION; TREATMENT OUTCOME;

EID: 77149179747     PISSN: 20056737     EISSN: 20056745     Source Type: Journal    
DOI: 10.4111/kju.2010.51.2.101     Document Type: Article

References (25)

1. Catalona WJ, Richie JP, Ahmann FR, Hudson MA, Scardino PT, Flanigan RC, et al. Comparison of digital rectal examination and serum prostate specific antigen in the early detection of prostate cancer: results of a multicenter clinical trial of 6,630 men. J Urol 1994;151:1283-90.
2. Park HK, Hong SK, Byun SS, Lee SE. Comparison of the rate of detecting prostate cancer and the pathologic characteristics of the patients with a serum PSA level in the range of 3.0 to 4.0 ng/ml and the patients with a serum PSA level in the range 4.1 to 10.0 ng/ml. Korean J Urol 2006;47:358-61.
3. Lee SC, Lee SC, Kim WJ. Value of PSA density, PSA velocity and percent free PSA for detection of prostate cancer in patients with serum PSA 4-10 ng/ml patients. Korean J Urol 2004;45:747-52.
4. Lee SJ, Seo IY, Kim JS, Rim JS. The effectiveness of free/total prostate specific antigen (PSA) ratio for increasing the detection rate of prostate cancer in patients with serum PSA level 4-10ng/ml. Korean J Urol 2001;42:815-20.
5. Lee TK, Chung TG, Kim CS. Age-specific reference ranges of prostate specific antigen from a health center in Korea. Korean J Urol 1999;40:583-8.
6. Kim BK, Chang SH, Kim CI. Clinical significance of prostate-specific antigen density in patients with serum prostate specific antigen between 4 and 10 ng/ml. Korean J Urol 2006;47:1161-5.
7. Rommel FM, Agusta VE, Breslin JA, Huffnagle HW, Pohl CE, Sieber PR, et al. The use of prostate specific antigen and prostate specific antigen density in the diagnosis of prostate cancer in a community based urology practice. J Urol 1994;151:88-93.
8. Zisman A, Leibovici D, Kleinmann J, Siegel YI, Lindner A. The impact of prostate biopsy on patient well-being: a prospective study of pain, anxiety and erectile dysfunction. J Urol 2001;165: 445-54.
9. Jones JS, Ulchaker JC, Nelson D, Kursh ED, Kitay R, Angie S, et al. Periprostatic local anesthesia eliminates pain of office-based transrectal prostate biopsy. Prostate Cancer Prostatic Dis 2003;6:53-5.
10. Kobayashi T, Mitsumori K, Kawahara T, Nishizawa K, Ogura K, Ide Y. Prostate gland volume is a strong predictor of biopsy results in men 70 years or older with prostate-specific antigen levels of 2.0-10.0 ng/mL. Int J Urol 2005;12:969-75.
11. Autorino R, De Sio M, Di Lorenzo G, Damiano R, Perdona S, Cindolo L, et al. How to decrease pain during transrectal ultrasound guided prostate biopsy: a look at the literature. J Urol 2005;174:2091-7.
12. Cha KS, Lee SW, Cho JM, Kang JY, Yoo TK. Efficacy and safety of intravenous propofol anesthesia during transrectal ultrasound-guided prostate biopsy. Korean J Urol 2009;50:757-61.
13. Shen BY, Chang PL, Lee SH, Chen CL, Tsui KH. Complications following combined transrectal ultrasound-guided prostate needle biopsies and transurethral resection of the prostate. Arch Androl 2006;52:123-7.
14. Gustafsson O, Norming U, Nyman CR, Ohström M. Complications following combined transrectal aspiration and core biopsy of the prostate. Scand J Urol Nephrol 1990;24:249-51.
15. Rietbergen JB, Kruger AE, Kranse R, Schröder FH. Complications of transrectal ultrasound-guided systematic sextant biopsies of the prostate: evaluation of complication rates and risk factors within a population-based screening program. Urology 1997;49:875-80.
16. Palisaar JR, Wenske S, Sommerer F, Hinkel A, Noldus J. Open radical retropubic prostatectomy gives favourable surgical and functional outcomes after transurethral resection of the prostate. BJU Int 2009;104:611-5.
17. Gohji K, Nomi M, Egawa S, Morisue K, Takenaka A, Okamoto M, et al. Detection of prostate carcinoma using prostate specific antigen, its density, and the density of the transition zone in Japanese men with intermediate serum prostate specific antigen concentrations. Cancer 1997;79:1969-76.
18. Zheng XY, Xie LP, Wang YY, Ding W, Yang K, Shen HF, et al. The use of prostate specific antigen (PSA) density in detecting prostate cancer in Chinese men with PSA levels of 4-10 ng/ml. J Cancer Res Clin Oncol 2008;134:1207-10.
19. Puppo P, Introini C, Calvi P, Naselli A. Role of transurethral resection of the prostate and biopsy of the peripheral zone in the same session after repeated negative biopsies in the diagnosis of prostate cancer. Eur Urol 2006;49:873-8.
20. Cho KJ, Ha US, Lee CB. Role of transurethral resection of the prostate in the diagnosis of prostate cancer for patients with lower urinary tract symptoms and serum PSA 4-10 ng/ml with a negative repeat transrectal needle biopsy of prostate. Korean J Urol 2007;48:1010-5.
21. Oesterling JE, Cooner WH, Jacobsen SJ, Guess HA, Lieber MM. Influence of patient age on the serum PSA concentration. An important clinical observation. Urol Clin North Am 1993;20:671-80.
22. Dalkin BL, Ahmann FR, Kopp JB. Prostate specific antigen levels in men older than 50 years without clinical evidence of prostatic carcinoma. J Urol 1993;150:1837-9.
23. Anderson JR, Strickland D, Corbin D, Byrnes JA, Zweiback E. Age-specific reference ranges for serum prostate-specific antigen. Urology 1995;46:54-7.
24. Choi YD, Kang DR, Nam CM, Kim YS, Cho SY, Kim SJ, et al. Age-specific prostate-specific antigen reference ranges in Korean men. Urology 2007;70:1113-6.
25. Meshref AW, Bazinet M, Trudel C, Aronson S, Peloquin F, Nachabe M, et al. Role of prostate-specific antigen density after applying age-specific prostate-specific antigen reference ranges. Urology 1995;45:972-9.